Concepedia

Author

Jolanthe Kropidlowski

Universität Hamburg

Also Known As

J. Kropidlowski, Jolanthe Kropidlowski, Kropidlowski, Jolanthe

38

Publications

336

Citations

11

H-Index

14

Concepts

All Affiliations

Universität HamburgUniversity Medical Center Hamburg-EppendorfUniversity of GroningenUniversity Hospital HeidelbergUniversity Cancer Center Hamburg
JK

About

Jolanthe Kropidlowski is an author at Universität Hamburg specializing in molecular diagnostics, pathology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

20

2

Public Health

1

1

20

3

Obstetrics

1

1

20

4

Pathology

1

1

20

5

Cervical Cancer

1

1

20

Jolanthe Kropidlowski

×

11

Publications

314

Citations

11

H-Index

YearCitations

Clonality of circulating tumor cells in breast cancer brain metastasis patients

Carlotta Riebensahm, Simon A. Joosse, Malte Mohme,

Breast Cancer Research

2019

72

Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression

Heidi Schwarzenbach, Corinna Eichelser, Jolanthe Kropidlowski,

Clinical Cancer Research

2012

65

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients

Harriet Wikman, Laura P. Westphal, Felicitas Schmid,

Oncotarget

2014

37

Peripheral and Portal Venous<i>KRAS</i>ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma

Christine Nitschke, Benedikt Markmann, Walter Philipp,

Clinical Chemistry

2023

24

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases

Harriet Wikman, Bettina Sielaff-Frimpong, Jolanthe Kropidlowski,

PLoS ONE

2012

22

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients

Markus Leffers, Johanna Herbst, Jolanthe Kropidlowski,

Cancers

2022

20

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Yassine Belloum, Melanie Janning, Malte Mohme,

Cells

2020

17

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Paul van der Leest, Melanie Janning, Naomi Rifaela,

International Journal of Molecular Sciences

2023

17

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Christine Nitschke, Benedikt Markmann, Marie Tölle,

Cancers

2022

14

Comparative evaluation of <scp><i>PD‐L1</i></scp> expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients

Mustafa Abdo, Yassine Belloum, David F. Heigener,

Molecular Oncology

2023

14

Page 1